Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Non-cash Items: 2014-2016

Historic Non-cash Items for Viridian Therapeutics, Inc.\DE (VRDN) over the last 2 years, with Dec 2016 value amounting to $37,465.

  • Viridian Therapeutics, Inc.\DE's Non-cash Items fell 51.97% to $37,465 in Q4 2016 from the same period last year, while for Dec 2016 it was $37,465, marking a year-over-year decrease of 51.97%. This contributed to the annual value of $37,465 for FY2016, which is 51.97% down from last year.
  • According to the latest figures from Q4 2016, Viridian Therapeutics, Inc.\DE's Non-cash Items is $37,465, which was down 85.71% from $262,194 recorded in Q3 2016.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Non-cash Items registered a high of $407,000 during Q1 2015, and its lowest value of $2,000 during Q2 2015.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Non-cash Items averaged around $167,293, with its median value being $132,378 (2016).
  • Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Non-cash Items slumped by 80.10% in 2015 and then skyrocketed by 7,339.90% in 2016.
  • Viridian Therapeutics, Inc.\DE's Non-cash Items (Quarterly) stood at $392,000 in 2014, then crashed by 80.10% to $78,009 in 2015, then tumbled by 51.97% to $37,465 in 2016.
  • Its Non-cash Items was $37,465 in Q4 2016, compared to $262,194 in Q3 2016 and $148,798 in Q2 2016.